Cardinal Health Ownership
| CAH Stock | USD 118.78 2.51 2.07% |
Shares in Circulation | First Issued 1985-06-30 | Previous Quarter 245 M | Current Value 245 M | Avarage Shares Outstanding 274.2 M | Quarterly Volatility 135.2 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Cardinal |
Cardinal Stock Ownership Analysis
About 89.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings To Growth (PEG) ratio of 1.06. Cardinal Health recorded earning per share (EPS) of 5.03. The entity last dividend was issued on the 2nd of January 2025. The firm had 3:2 split on the 23rd of April 2001. Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. The company was incorporated in 1979 and is headquartered in Dublin, Ohio. Cardinal Health operates under Medical Distribution classification in the United States and is traded on New York Stock Exchange. It employs 46500 people. For more info on Cardinal Health please contact Michael Kaufmann at 614 757 5000 or go to https://www.cardinalhealth.com.Besides selling stocks to institutional investors, Cardinal Health also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Cardinal Health's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Cardinal Health's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Cardinal Health Quarterly Liabilities And Stockholders Equity |
|
Cardinal Health Insider Trades History
Less than 1% of Cardinal Health are currently held by insiders. Unlike Cardinal Health's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Cardinal Health's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Cardinal Health's insider trades
Cardinal Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Cardinal Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Cardinal Health backward and forwards among themselves. Cardinal Health's institutional investor refers to the entity that pools money to purchase Cardinal Health's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Jpmorgan Chase & Co | 2024-06-30 | 3.1 M | Bank Of America Corp | 2024-06-30 | 3 M | Northern Trust Corp | 2024-06-30 | 2.7 M | Legal & General Group Plc | 2024-06-30 | 2.6 M | Ubs Asset Mgmt Americas Inc | 2024-06-30 | 2.5 M | Lsv Asset Management | 2024-06-30 | 2.3 M | Amundi | 2024-06-30 | 2.1 M | T. Rowe Price Associates, Inc. | 2024-06-30 | 2.1 M | Norges Bank | 2024-06-30 | 2.1 M | Blackrock Inc | 2024-06-30 | 30.8 M | Vanguard Group Inc | 2024-06-30 | 30.6 M |
Cardinal Health Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Cardinal Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Cardinal Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Cardinal Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Carole Watkins over a year ago Bona fide gift to Carole Watkins of 162 shares of Cardinal Health subject to Section 16 | ||
Deborah Weitzman over a year ago Acquisition by Deborah Weitzman of 12760 shares of Cardinal Health subject to Rule 16b-3 |
Cardinal Health's latest congressional trading
Congressional trading in companies like Cardinal Health, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Cardinal Health by those in governmental positions are based on the same information available to the general public.
| 2024-09-23 | Representative Marjorie Taylor Greene | Acquired Under $15K | Verify | ||
| 2024-09-06 | Representative John James | Acquired Under $15K | Verify | ||
| 2024-09-02 | Representative John James | Acquired Under $15K | Verify |
Cardinal Health Outstanding Bonds
Cardinal Health issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Cardinal Health uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Cardinal bonds can be classified according to their maturity, which is the date when Cardinal Health has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| CARDINAL HEALTH INC Corp BondUS14149YAW84 | View | |
| CARDINAL HEALTH INC Corp BondUS14149YBJ64 | View | |
| CARDINAL HEALTH INC Corp BondUS14149YBE77 | View | |
| CARDINAL HEALTH INC Corp BondUS14149YBD94 | View | |
| CARDINAL HEALTH INC Corp BondUS14149YBA55 | View | |
| CARDINAL HEALTH INC Corp BondUS14149YBB39 | View | |
| CARDINAL HEALTH INC Corp BondUS14149YBM93 | View |
Cardinal Health Corporate Filings
F4 | 14th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 13th of November 2024 Other Reports | ViewVerify | |
8K | 12th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 24th of October 2024 An amended filing to the original Schedule 13G | ViewVerify |
Currently Active Assets on Macroaxis
When determining whether Cardinal Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cardinal Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cardinal Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cardinal Health Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardinal Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For more detail on how to invest in Cardinal Stock please use our How to Invest in Cardinal Health guide.You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cardinal Health. If investors know Cardinal will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cardinal Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 48.135 | Dividend Share 2.012 | Earnings Share 5.03 | Revenue Per Share 921.782 | Quarterly Revenue Growth (0.04) |
The market value of Cardinal Health is measured differently than its book value, which is the value of Cardinal that is recorded on the company's balance sheet. Investors also form their own opinion of Cardinal Health's value that differs from its market value or its book value, called intrinsic value, which is Cardinal Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cardinal Health's market value can be influenced by many factors that don't directly affect Cardinal Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cardinal Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cardinal Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cardinal Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.